Journal
CURRENT PSYCHIATRY REPORTS
Volume 14, Issue 6, Pages 659-666Publisher
SPRINGER
DOI: 10.1007/s11920-012-0320-9
Keywords
Alcohol use disorder; AUD; Bipolar disorder; BD; Comorbidity; Genetics; Neuroimaging; Treatment; Integrated; Psychotherapy; Pharmacotherapy; Treatment program; FIRESIDE; Integrated group therapy; Psychiatry
Categories
Funding
- National Institute on Drug Abuse [K24DA022288, K99/R00DA029115]
Ask authors/readers for more resources
Bipolar disorder and alcohol use disorder represent a significant comorbid population, which is significantly worse than either diagnosis alone in presentation, duration, co-morbidity, cost, suicide rate, and poor response to treatment. They share some common characteristics in relation to genetic background, neuroimaging findings, and some biochemical findings. They can be treated with separate care, or ideally some form of integrated care. There are a number of pharmacotherapy trials, and psychotherapy trials that can aid program development. Post-treatment prognosis can be influenced by a number of factors including early abstinence, baseline low anxiety, engagement with an aftercare program and female gender. The future development of novel therapies relies upon increased psychiatric and medical awareness of the co-morbidity, and further research into novel therapies for the comorbid group.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available